Abstract:Background Cellular FLICE-Inhibitory Protein (long form, c-FLIP L ) is a critical negative regulator of death receptor-mediated apoptosis. Overexpression of c-FLIP L has been reported in many cancer cell lines and is associated with chemoresistance. In contrast, down-regulation of c-FLIP may drive cancer cells into cellular apoptosis. This study aims to demonstrate that inhibition of the heat shock protein 90 (Hsp90) either by inhibitors geldanamycin/17-N-Allylamino-17-demethoxygeldanamycin (GA/17-AAG) or siRNA technique in human lung cancer cells induces c-FLIP L degradation and cellular apoptosis through C-terminus of Hsp70-interacting protein (CHIP)-mediated mechanisms. Methods Calu-1 and H157 cell lines (including H157-c-FLIP L overexpressing c-FLIP L and control cell H157-lacZ) were treated with 17-AAG and the cell lysates were prepared to detect the given proteins by Western Blot and the cell survival was assayed by SRB assay. CHIP and Hsp90 α/β proteins were knocked down by siRNA technique. CHIP and c-FLIP L plasmids were transfected into cells and immunoprecipitation experiments were performed to testify the interactions between c-FLIP L , CHIP and Hsp90. Results c-FLIP L down-regulation induced by 17-AAG can be reversed with the proteasome inhibitor MG132, which suggested that c-FLIP L degradation is mediated by a ubiquitin-proteasome system. Inhibition of Hsp90α/β reduced c-FLIP L level, whereas knocking down CHIP expression with siRNA technique inhibited c-FLIP L degradation. Furthermore, c-FLIP L and CHIP were co-precipitated in the IP complexes. In addition, overexpression of c-FLIP L can rescue cancer cells from apoptosis. When 17-AAG was combined with an anti-cancer agent celecoxib(CCB), c-FLIP L level declined further and there was a higher degree of caspase activation. Conclusion We have elucidated c-FLIP L degradation contributes to apoptosis induced by Hsp90 inhibition, suggesting c-FLIP and Hsp90 may be the promising combined targets in human lung cancer treatment.

Critical role for c-FLIPL on Fas resistance in colon carcinoma cell line HT-29

Effect of FLIP small interfering RNA on apoptosis of colorectal cancer cells

Expression of Cellular FLICE-like Inhibitory Protein Long Form Mrna in Colon Cancer and Its Clinical Significance

Functional investigation of Fas ligand expressions in human non-small cell lung cancer cells and its clinical implications.

Fas-mediated Pathway and Apoptosis in Normal Cervix, Cervical Intraepithelial Neoplasia and Cervical Squamous Cancer.

Analysis of Fas and Fas Ligand expression and function in lung cancer cell lines

Loss of Fas Expression and Function is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy.

Overexpression of Cflip in Head and Neck Squamous Cell Carcinoma and Its Clinicopathologic Correlations

Expression of Cellular FLICE-inhibitory Protein and Its Association with P53 Mutation in Colon Cancer.

Down-regulation of cellular FLICE-inhibitory protein (Long Form) contributes to apoptosis induced by Hsp90 inhibition in human lung cancer cells

Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer

Interference of e-FLIP by siRNA in Hepatocarcinoma cell line HepG2

Fas Ligand Expression in Colon Cancer: A Possible Mechanism of Tumor Immune Privilege

Resistance To Fas-Mediated Apoptosis In Malignant Tumours Is Rescued By Kn-93 And Cisplatin Via Downregulation Of C-Flip Expression And Phosphorylation

Research progress of FLIP in cancer

Considering Fas ligand as a target for therapy.

C-FLIPL Modulated Wnt/β-Catenin Activation via Association with TIP49 Protein

Expression of FLIP in Human Colon Carcinomas: A New Mechanism of Immune Evasion

Suppression of C-Flipl Promotes Jnk Activation in Malignant Melanoma Cells

Effects of c-FLIP antisense oligodeoxynucleotides on growth and apoptosis of lung cancer cell line A549

FLI-1 mediates tumor suppressor function via Klotho signaling in regulating CRC